A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

Rosenthal, Seth A., MD ; Hunt, Daniel, PhD ; Sartor, A. Oliver, MD ; Pienta, Kenneth J., MD ; Gomella, Leonard, MD ; Grignon, David, MD ; Rajan, Raghu, MD ; Kerlin, Kevin J., MD ; Jones, Christopher U., MD ; Dobelbower, Michael, MD ; Shipley, William U., MD ; Zeitzer, Kenneth, MD ; Hamstra, Daniel A., MD, PhD ; Donavanik, Viroon, MD ; Rotman, Marvin, MD ; Hartford, Alan C., MD ; Michalski, Jeffrey, MD ; Seider, Michael, MD ; Kim, Harold, MD ; Kuban, Deborah A., MD ; Moughan, Jennifer, MS ; Sandler, Howard, MD

International journal of radiation oncology, biology, physics, 2015-10, Vol.93 (2), p.294-302 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível